Startups

Platform to automate the clinical studies process.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 23,000 COMPANIES →

Summary

Seedtable Score

Score icon 67

Locations

Company Size

  • 11 - 51

Last Stage Round

Insights

Umedeor, based in London, demonstrates strong potential by targeting inefficiencies in the clinical studies process. By automating documentation, tracking, and data analysis, Umedeor addresses significant industry pain points such as slow study completion, frequent errors, and high costs associated with manual methods. This specialization offers a compelling value proposition for biotech and health tech companies aiming to streamline operations and improve accuracy. Supported by notable investors, Umedeor is well-positioned to capture substantial market share by transforming how clinical studies are managed.

Total Funding
$12.4M

Investors

Full Company Profile